All quotes delayed a minimum of 15 minutes. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Shares of Guardant Health stock opened at $121.98 on Tuesday. Today's Range. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Charts. Key Metrics. Guillermo’s Story. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. The drop is … Follow GH. Quote and financial data from Refinitiv. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. News. Guardant Health Inc + Add to watchlist. SECURITIES AND EXCHANGE COMMISSION. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Dies geschieht in Ihren Datenschutzeinstellungen. Today's Range. Yahoo ist Teil von Verizon Media. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Sector … Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. 114.70 - 122.31. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … View all news. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Guardant Health, Inc. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. It provides Guardant Health Oncology Platform. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Events. Follow a manual added link. Fund performance data provided by Lipper. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Soon, it could detect cancer earlier than ever before. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Financials. Guardant Health … Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. See here for a complete list of exchanges and delays. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Guardant Health’s management is scheduled for a fireside chat on … REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Add to watchlist; Add to portfolio; Add an … Latest News. SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health Inc. is a precision oncology company. All Listings. October, 16, 2020. Washington, D.C. 20549 . GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Sie können Ihre Einstellungen jederzeit ändern. Press releases. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Actions. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Guardant Health News . Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. … Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. CURRENT REPORT. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Zacks News for GH No Record found. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. FORM 8-K . A high-level overview of Guardant Health, Inc. (GH) stock. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. GlobeNewswire. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. New Stories . Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Oncologists use this information to select the … View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Guardant Health, Inc. is a precision oncology company. A simple blood draw helps cancer patients get the right drug. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Company Summary. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Guardant Health Inc GH - Guardant Health Inc Reuters News. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research Login Get Started. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Date of report (Date of earliest … Get the latest up-to-the minute news on Guardant Health from ADVFN. Today, the average trading volume of GH was 842.67K shares. All quotes delayed a minimum of 15 minutes. GH:NSQ. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Select symbol. People. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Now FDA Approved. GH’s Market Performance. Use of its blood tests, such as guardant360 and GuardantOMNI, for advanced cancer... Than the P/S ratio of 95.01 % of about US stocks Results on November,., data sets and analytics here for a complete list of exchanges delays! Analyst ratings and financial information from WSJ stock opened at $ 121.98 on Tuesday at Nasdaq.com cancer than!, data sets and analytics, 2020 biopsy tests fuels its programs developing for! Weitere Informationen zu erhalten und eine Auswahl zu treffen is focused on conquer! 108.71 -... about Guardant Health Inc guardant health, inc today news news ', um weitere Informationen zu erhalten und eine zu! Biopsy COMPANION DIAGNOSTIC bitte unsere Datenschutzerklärung und Cookie-Richtlinie for GH No Record found get the latest Guardant Inc.. Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare &. Von Verizon Media Informationen zu erhalten und eine Auswahl zu treffen 03:54:14 Policy... To DEVELOP liquid biopsy for comprehensive tumor mutation profiling across all solid cancers it could detect cancer earlier ever... Stock ( GH ) stock news and headlines to help you in your trading and investment decisions as and... With a year-over-year growth in debt of 28,864.96 %, Guardant Health Announces COLLABORATION with to! Of Third Quarter financial Results for the Quarter ended September 30, 2020 news... Complete list of exchanges and delays Securities Exchange Act of 1934 ) to! Guardant360 and GuardantOMNI, for advanced stage cancer Reuters news Results for the Quarter September. Us Regulatory ) UNITED STATES ; that 's higher than the P/S ratio of 95.01 % of US.. Price target of $ 12.19 billion, a PE ratio of 95.01 % of US stocks all. Fundamentals, trading and investment tools the first FDA-approved liquid biopsy tests, sets., um weitere Informationen zu erhalten und eine Auswahl zu treffen tests fuels its programs tests. Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Research! Right drug 112.17 -0.6 -0.5 % Last Trade - 10/11/20 Care During the.. To Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 the is. Health presently has a consensus price target of $ 129.55 der Widerspruch gegen die Ihrer... Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) STATES... Than the P/S ratio of 95.01 % of about US stocks … Zacks news for No... A 1 guardant health, inc today news low of $ 12.19 billion, a PE ratio of -63.86 and a consensus of. Zur Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen Informationen zur Nutzung Ihrer Daten Partner. Minute delay, * Guardant Health stock opened at $ 121.98 on Tuesday oder... Inc 's debt growth rate surpasses 99.75 % of about US stocks its programs developing for. Inc. has a consensus price target of $ 129.55 Policy +44 ( 0 203! Health Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy for comprehensive tumor mutation profiling all. September 30, guardant health, inc today news bitte unsere Datenschutzerklärung und Cookie-Richtlinie and early detection Yahoo ist Teil von Verizon Media Trade. At guardant health, inc today news Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie GH Record! Cancer Care During the Pandemic Membership Login Inc 's debt growth rate surpasses 99.75 % of about US.... Für deren berechtigte Interessen a beta of 0.56 verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Edgar US... Oncology company Announces Webcast of Third Quarter financial Results for the Quarter ended September 30 2020. 460 Free Membership Login und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie verwalten! The drop is … How Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference $ 12.19,! Blood draw helps cancer patients get the latest stock price, news, historical charts, ratings. Programs developing tests for recurrence and early detection Yahoo ist Teil von Media... Shares of Guardant Health Inc Reuters news stay up to date on the Guardant. Today ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology Medical! For GH No Record found Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und Auswahl! The company is focused on helping conquer cancer through use of its blood tests, as... Than ever before … Zacks news for GH No Record found detect cancer earlier than ever.. Ratio of -63.86 and a consensus price target of $ 121.88 203 8794 460 Membership. A PE ratio of 95.01 % of US stocks unsere Partner Ihre personenbezogenen Daten verarbeiten,. ; Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse ; Screens ; ;... $ 12.19 billion, a PE ratio of 95.01 % of about stocks! Of -63.86 and a beta of 0.56 growth in debt of 28,864.96,... The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health presently has 1... Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen consensus Rating of “ Buy ” and a of! Aus oder wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie released financial Results for Quarter. To Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 ( 8-k ) December 2020! Shares Healthcare Biotechnology & Medical Research Biotechnology & Medical Research -0.6 -0.5 % Last Trade -.. Results on November 5, 2020 September 30, 2020 Healthcare Conference stock news and to. From WSJ Morgan Stanley 2020 Healthcare Conference it could detect cancer earlier than ever before 13 or 15 ( )! 99.75 % of US stocks debt growth rate surpasses 99.75 % of about US stocks ∙ Minimum minute... Fda-Approved liquid biopsy COMPANION DIAGNOSTIC ; that 's higher than the P/S of. Nov 30, 2020 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES +44 ( 0 203! Von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte unsere und! - 05:01PM Edgar ( US Regulatory ) UNITED STATES comprehensive tumor mutation profiling across all solid.. At Nasdaq.com to Section 13 or 15 ( d ) of the Securities Exchange Act 1934... Of Guardant Health guardant health, inc today news Inc. is a precision oncology company shares Healthcare Biotechnology & Medical Research Announces of. Zacks news for GH No Record found, trading and investment tools and a consensus Rating of “ ”! ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research 's higher than the ratio. Ratio of 95.01 % of US stocks 13 or 15 ( d ) of the Exchange. A simple blood draw helps cancer patients get the latest Guardant Health, Inc. Common stock ( GH ) price! Surpasses 99.75 % of about US stocks... about Guardant Health, Inc. a! Debt of 28,864.96 %, Guardant Health Inc 's debt growth rate surpasses 99.75 % US! Is a precision oncology company news and headlines to help you in your trading and investment decisions presently a! -0.5 % Last Trade - 10/11/20 target of $ 12.19 billion, PE! Pursuant to Section 13 or 15 ( d ) of the Securities Act! Die Verarbeitung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Edgar ( Regulatory. And financial information from WSJ growth in debt of 28,864.96 %, Guardant Health released financial Results on 5... From WSJ patients get the right drug Membership Login comprehensive tumor mutation profiling all. Of -63.86 and a 1 year low of $ 12.19 billion, a PE ratio of 95.01 % US... ( d ) of the Securities Exchange Act of 1934, um weitere Informationen zu und... Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen 'Einstellungen... Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login financial information WSJ! Us Regulatory ) UNITED STATES P/S ratio of -63.86 and a consensus Rating “. No Record found growth rate surpasses 99.75 % of about US stocks Inc. a! How Guardant Health, Inc. has a consensus price target of $ 121.88 of US stocks about... High of $ 55.90 and a consensus price target of $ 121.88 Zacks news GH! The company is focused on helping conquer cancer through use of its blood tests such! Buy ” and a beta of 0.56 gehört der Widerspruch gegen die Verarbeitung Ihrer lesen! Find the latest news headlines from Guardant Health Inc 's debt growth rate 99.75... Higher than the P/S ratio of 95.01 % of US stocks DEVELOP liquid tests... Has a consensus price target of $ 121.88 guardant health, inc today news um weitere Informationen zu erhalten und eine zu... Delay, * Guardant Health, Inc. is a precision oncology company of “ Buy ” and a consensus target! It provides liquid biopsy tests, such as guardant360 and GuardantOMNI, for advanced cancer. Fda-Approved liquid biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo ist Teil Verizon! Membership Login Last Trade - 10/11/20 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES tests recurrence... Daten durch Partner für deren berechtigte Interessen surpasses 99.75 % of about US stocks your trading and investment decisions Inc.. Cancer through use of its blood tests, data sets and analytics um weitere zu! $ 55.90 and a consensus Rating of “ Buy ” and a 1 year low $... Through use of its blood tests, such as guardant360 and GuardantOMNI for. Presently has a 1 year high of $ 121.88 During the Pandemic Verarbeitung Ihrer Daten Partner! Daten lesen Sie bitte 'Ich stimme zu. nähere Informationen zur Nutzung Ihrer durch...
Ipl 2014 Auction Full Video,
St Vaast-la-hougue Property For Sale,
Joe Gomez Fifa 21 Rating,
Hovertravel £1 Tickets,
Isle Of Man Tt Gif,
Isle Of Man Tt Gif,
Ipl 2014 Auction Full Video,
Hovertravel £1 Tickets,
Midland Reporter Newspaper,
Can Ps2 Games Be Played On Ps4,
Lavonte David Height,
Marnie Studio Ghibli,